Bayer Diagnostics strikes deal with AmeriNet:
This article was originally published in Clinica
Executive Summary
The diagnostics division of German pharmaceutical company Bayer has entered into a three-year agreement with AmeriNet for clinical systems for both urinalysis and immunodiagnostics. AmeriNet is one of the largest membership-based group purchasing organisations in the US, representing 4,500 member facilities or 300,000 hospital beds.